Related Experiment Video
Updated: Jun 5, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
The plasma homocysteine concentrations and prior myocardial infarction
Lucia Agoşton-Coldea1, Teodora Mocan, Andrada Seicean
1Department of Medical Sciences, Iuliu Haţieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. luciacoldea@yahoo.com
Insights
Elevated plasma homocysteine levels predict cardiovascular events and correlate with coronary artery disease severity. This study suggests homocysteine as a valuable clinical marker for cardiovascular risk assessment.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
Background:
- Elevated plasma homocysteine is linked to vascular disease and cardiovascular event risk.
- Homocysteine levels may correlate with disease severity in patients with coronary artery disease.
Purpose of the Study:
- To analyze the relationship between homocysteine concentrations and coronary artery disease (CAD) progression.
- To evaluate homocysteine as a predictor of cardiovascular events in patients with prior myocardial infarction.
Main Methods:
- A study involving 208 patients, divided into those with prior myocardial infarction (n=104) and a control group without coronary artery disease (n=104).
- Plasma homocysteine levels were measured and analyzed in relation to cardiovascular risk factors and disease presence.
Main Results:
- Patients with prior myocardial infarction exhibited significantly higher mean plasma homocysteine levels compared to controls (18.98 ± 4.72 vs. 14.09 ± 3.32 µmol/L, p < 0.001).
- Multivariate analysis identified homocysteine >15 µmol/L as an independent cardiovascular risk factor (OR 2.05; 95% CI 1.56-2.54).
- Receiver Operator Curve analysis indicated good reliability for homocysteine in diagnosing coronary artery disease (AUC = 0.671, p < 0.001).
Conclusions:
- A positive correlation was observed between plasma homocysteine levels and the severity of coronary lesions (r = 0.765, p < 0.005).
- The findings support the use of plasma homocysteine as a clinical marker for cardiovascular risk assessment.
Unlabelled:
Elevated plasma homocysteine levels are associated with increased risk of vascular disease and with a relationship between homocysteine values and disease severity. Several studies have shown that the high plasma level of homocysteine is an important predictor for risk of cardiovascular events. We analysed the relationship between homocysteine concentrations and other risk factors into CAD progression in patients of prior myocardial infarction.
Methods:
We performed a study including 208 patients (100 men and 108 women) divided into two groups: 104 patients with prior myocardial infarction and 104 without coronary artery disease.
Results:
The patients with prior myocardial infarction had higher mean values of plasma homocysteine than the controls (18.98 +/- 4.72 vs. 14.09 +/- 3.32 micromol/L, p < or = .001). Multivariate analysis after the adjustment for age, gender and cardiovascular risk factors has identified homocysteine over 15 micromol/L as significant and independent cardiovascular risk factors (odds ratio 2.05; 95% CI 1.56-2.54). The correspondent Receiver Operator Curve shape suggested a good reliability in diagnosis of coronary artery disease for homocysteine (under curve area = 0.671, p < or = 001).
Conclusion:
Our results showed a positive correlation between plasma homocysteine levels and severity of coronary lesions (r = 0.765, p < .005). We suggest the use of homocysteine in clinical practice as marker of cardiovascular risk assessment.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction